Financial reports
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
14 Apr 23
NT 10-K
Notice of late annual filing
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
13 Apr 22
NT 10-K
Notice of late annual filing
1 Apr 22
Current reports
8-K
Departure of Directors or Certain Officers
22 Mar 21
8-K
Vycor Medical, Inc. Agrees New NovaVision Licensing Agreement
30 Jun 20
8-K
Vycor Medical Reports Financial Results for the year ended December 31st, 2019
27 Mar 20
8-K
Vycor Medical Reports Financial Results for the year ended December 31st, 2018
29 Mar 19
8-K
Changes in Registrant's Certifying Accountant
12 Oct 18
8-K
Vycor Medical Reports Financial Results for the year ended December 31st, 2017
30 Mar 18
8-K
Vycor Medical Reports Financial Results for the three and nine months ended September 30th, 2017
13 Nov 17
8-K
Vycor Medical Reports Financial Results for the three and six months ended June 30th, 2017
11 Aug 17
8-K
Vycor Medical Reports Financial Results for the Period ended March 31st, 2017
11 May 17
8-K
Vycor Medical Reports Financial Results for the year ended December 31st, 2016
31 Mar 17
Registration and prospectus
D
$1M in equity / options, sold $618.61K, 54 investors
23 Jan 17
424B3
Prospectus supplement
21 Oct 16
POS AM
Prospectus update (post-effective amendment)
5 Oct 16
424B3
Prospectus supplement
23 Sep 15
AW
Withdrawal of amendment
4 Sep 15
POS AM
Prospectus update (post-effective amendment)
4 Sep 15
POS AM
Prospectus update (post-effective amendment)
7 Aug 15
POS AM
Prospectus update (post-effective amendment)
24 Jul 15
424B3
Prospectus supplement
11 Jun 14
AW
Withdrawal of amendment
10 Jun 14
Proxies
DEF 14C
Information statement
13 Mar 18
PRER14C
Preliminary revised information
1 Mar 18
PRE 14C
Preliminary information
12 Feb 18
DEF 14C
Information statement
19 Dec 12
PRE 14C
Preliminary information
5 Dec 12
DEF 14C
Information statement
21 Jun 10
PRE 14C
Preliminary information
9 Jun 10
DEFR14C
Revised information
22 Dec 09
DEF 14C
Information statement
11 Dec 09
PRER14C
Preliminary revised information
11 Dec 09
Other
UPLOAD
Letter from SEC
18 Nov 16
CORRESP
Correspondence with SEC
8 Nov 16
UPLOAD
Letter from SEC
31 Oct 16
EFFECT
Notice of effectiveness
14 Oct 16
EFFECT
Notice of effectiveness
18 Sep 15
EFFECT
Notice of effectiveness
10 Jun 14
EFFECT
Notice of effectiveness
6 Nov 13
UPLOAD
Letter from SEC
28 Oct 13
CORRESP
Correspondence with SEC
23 Oct 13
UPLOAD
Letter from SEC
10 Oct 13
Ownership
SC 13D/A
FOUNTAINHEAD CAPITAL MANAGEMENT LTD
18 Oct 22
4
Change in insider ownership
18 Oct 22
4
Change in insider ownership
13 Jul 22
SC 13D/A
FOUNTAINHEAD CAPITAL MANAGEMENT LTD
13 Jul 22
SC 13D/A
FOUNTAINHEAD CAPITAL MANAGEMENT LTD
13 Apr 22
4
Change in insider ownership
13 Apr 22
4
Change in insider ownership
18 Jan 22
SC 13D/A
FOUNTAINHEAD CAPITAL MANAGEMENT LTD
18 Jan 22
SC 13D/A
FOUNTAINHEAD CAPITAL MANAGEMENT LTD
8 Oct 21
4
Change in insider ownership
8 Oct 21